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Diet and polycystic kidney disease: A pilot intervention study
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SUMMARY
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Background & aims—Dietary sodium, protein, acid precursors, and water have been linked to
cyst growth in polycystic kidney disease; yet, no studies in patients have examined the feasibility
of using a dietary intervention that controls all of these factors. The aim of this study was to
determine if a diet, appropriate for persons of most ages, reduces the excretion of sodium, urea,
acid, and decreases mean urine osmolality while gaining acceptance by patients with autosomal
dominant polycystic kidney disease (ADPKD).
Methods—Twelve adults with ADPKD enrolled in a pre-post pilot feasibility study and served as
their own controls. Individuals consumed their usual diet for one week then for four weeks
followed an isocaloric diet lower in sodium and protein and higher in fruits, vegetables, and water.
Three-day diet records and two 24-h urine samples were collected at baseline, week 2, and week 4
visits; blood pressure, weight, and serum were obtained at all three visits. A modified nutrition
hassles questionnaire was completed on the last visit.
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Results—During the dietary intervention, subjects (n = 11) consumed less sodium, protein, and
dietary acid precursors 36%, 28%, and 99%, respectively, and increased fluid intake by 42%.
Urinary sodium, urea, net acid excretion, osmoles, and osmolality decreased 20%, 28%, 20%,
37%, and 15%, respectively; volume increased 35%. Urine changes were in accord with the diet
record. Ninety-one percent of participants reported that none of the hassles were worse than
“somewhat severe”, and most participants felt “somewhat confident” or “very confident” that they
could manage the new diet.
Conclusions—A majority of adult patients with ADPKD successfully prepared and followed a
composite diet prescription with decreased sodium, protein, acid precursors, and increased fluid
intake. This trail was registered at ClinicalTrials.gov (NCT01810614).
Keywords
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Polycystic kidney disease; Renal nutrition; Net acid excretion; Potential renal acid load; Dietary
acid load; Net endogenous acid production

1. Introduction

Author Manuscript

Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder that affects
~600,000 individuals in the United States and ~12.5 million people worldwide [1]. The
clinical hallmark of ADPKD is the development of cysts in individual renal tubules that
enlarge progressively throughout life. Although cysts begin forming during fetal
development, the glomerular filtration rate (GFR) usually stays within an apparently normal
range for several decades owing to compensatory hyperfiltration [2]. Meanwhile, cysts
increase in number and volume, causing serious injury to blood vessels and renal tubules.
Recent evidence indicates that kidney volume predicts the likelihood of developing renal
insufficiency over time, suggesting that the growth of cysts is linked to declining kidney
function [3].
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The disease phenotype is highly variable causing differing rates of cyst growth even among
members of the same family [4]. Dietary factors appear to account for some of the
variability in this rate of renal enlargement; a process that appears to be hastened by the
excessive intake of salt and animal-sourced protein [5,6]. Additionally, increased urinary
acid excretion accelerates cyst growth in experimental animals and leads to a more rapid
decline in kidney function in patients with moderately advanced chronic progressive renal
diseases, including ADPKD [5,7–14]. Acid excretion is largely driven by high intakes of
animal-sourced dietary protein, but can be reduced by base-producing fruits and vegetables
[15]. Increasing fluid intake has also been shown to reduce kidney weight (% of total body
weight) by 27–30% by lowering plasma levels of arginine vasopressin (AVP); a result
achieved when reaching a urine osmolality of <290 mosm/kg H2O [16]. In view of this
evidence, we aimed to determine if a relatively complex dietary prescription targeting
dietary salt, protein, acid precursors, and fluid intake would be meaningfully adopted by
adult patients with ADPKD.
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2. Materials and methods
2.1. Study population
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Twelve subjects with a certain diagnosis of ADPKD confirmed by family history, magnetic
resonance, computed tomography or ultrasound imaging were enrolled [1]. Subjects were
recruited from the University of Kansas Medical Center Polycystic Kidney Disease clinic
during routine visits between May 2013 and January 2014. Inclusion in the study required a
blood pressure <135/85 mmHg, stable weight and clinical biochemistry, a diet history of >30
mEq/ day of net endogenous acid production (NEAP), and an estimated GFR (eGFR) of >30
ml/min/1.73 m2 based on the MDRD-EPI equation [17]. Subjects were excluded if they used
pharmaceuticals or dietary restrictions/enhancements for preexisting medical conditions not
associated with standard of care for ADPKD or if they had been prescribed medications that
affect acid/base status. A physical examination was performed by a physician to confirm
medical appropriateness to participate. Written informed consent was obtained prior to study
enrollment. This study was approved by the Human Subject Committee at the University of
Kansas Medical Center. This trial was registered at clinicaltrials.gov (NCT01810614). A
physician co-investigator monitored data and safety.
2.2. Study design
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Subjects were enrolled for a five-week study that included an enrollment visit, three study
visits (baseline, 2 weeks, 4 weeks) and two follow-up phone calls (Fig. 1). Study visits
occurred in the clinical and translational science unit. Each subject submitted a three-day
diet record (three days prior to study visits regardless of weekday or weekend), two
consecutive 24-h urine collections (two days prior to study visit), and a study nurse recorded
blood pressures, anthropometrics, and drew blood samples at each visit. All subjects
received instructions on how to modify their diet and served as their own controls in this prepost pilot feasibility study.
2.3. Three-day diet records
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Diet records included a detailed accounting of all food and beverage consumed, the amounts
consumed, the method of food preparation, and, if homemade, the recipe that was used. The
amount of food consumed was measured by weight on an electronic food scale or by typical
volumetric household measures. If neither of these methods of measurement were available,
participants were asked to estimate portion sizes using picture books that were provided.
Diet records were analyzed at each visit using the Nutrition Data for System Research
(NDSR version 2012) [18]. To improve collection of dietary data, probing techniques and a
multiple pass system were used during study visits to gather information that subjects may
have omitted or recorded incorrectly [19].
2.4. Urine measurements
Participants were instructed at the enrollment visit on how to collect 24-h urine samples.
Instructions included detailed methods for properly recording start and stop times and when
to switch to the second 24-h collection. Written instructions were also provided. Timed 24-h
urine collections were completed on the two days prior to each visit and coincided with the
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last two days of the diet record. Urine collections were kept on ice or placed in a refrigerator
throughout the duration of each timed collection. Urine volume was determined from the
weight of the collected sample. Aliquots of urine were centrifuged, and stored immediately
at −20 C for the later measurement of urinary acid excretion [20]. The remaining urine was
sent immediately to the University of Kansas Hospital lab for analysis of electrolytes, urea,
creatinine, bicarbonate, and osmolality.
2.5. Other measurements
Height was measured without shoes using a stadiometer and weight was recorded with
participants without shoes in street clothes. Subjects were supine for the measurement of
blood pressure. Electrolytes, blood urea nitrogen (BUN), creatinine, uric acid, glucose, and
bicarbonate were determined in serum samples by the hospital laboratory.
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2.6. Diet and urine calculations
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2.6.1. Diet—Three-day diet records were used to calculate net endogenous acid production
from the formula NEAP = PRAL + organic acids (OA) and the mean recorded. NEAP is
used to predict the amount of acid excreted in the urine [21,22]. The first term, PRAL,
estimates the potential net acid or base contribution a food or liquid would make when
combusted by whole body metabolism [23]. The daily PRAL was calculated from all food
and drink consumed over the day by estimating the dietary intake of anions (phosphorus and
sulfur) and cations (potassium, calcium, and magnesium) from diet records using nutrient
profiles from NDSR; sulfur was estimated based on the normative content of methionine and
cysteine derived from protein in the diet. The fractional absorption of nutrients by the
intestines, the dissociation of phosphate, and ionic valences are all taken into account in
Remer’s method for determining PRAL [21,23]. Daily consumption of these anions and
cations was entered into an excel program developed by the research team that accounts for
the variables listed in Remer’s equation to generate the daily PRAL of the diet. The second
component of the equation, OA, is estimated from body surface area according to
Berkemeyer and Remer [24]. Given the time frame and stable body weight in this study, we
assumed that OA excretion was also stable.
2.6.2. Urine—Net acid excretion (NAE) is a direct measure of acid/alkali excretion in the
urine and is determined from the sum of titratable acid + ammonium − bicarbonate [15].
NEAP predicts acid in the urine and should approximate NAE. NAE was measured within 3
months of sample collection using standard methods [20].
2.7. Diet prescription

Author Manuscript

The experimental diet was tailored for individual subjects based on their baseline dietary
intake of sodium, protein and NEAP (derived from three-day diet records) and
measurements of urine osmolality and urine volume obtained from two 24-h urine
collections (Table 1) [18,22,25]. The test diet was followed for the next four-weeks. At
baseline, subjects received detailed instruction from a registered dietitian about limiting the
intake of salt and protein while increasing the intake of fruits, vegetables, and fluid.
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2.7.1. Sodium—The daily limit for sodium in the test diet (1–1.5 mEq/kg) was
apportioned over the course of the day based on the number of meals and snacks a
participant typically ate. Each subject’s diet was uniquely modified in this manner to change
their usual dietary pattern as little as possible. Subjects were informed of the sources of
sodium in their diet, how to read food labels, and how to access nutrition information from
restaurants and food companies online. Educational materials from the American Heart
Association were provided to help educate subjects about dietary sodium [26].
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2.7.2. Protein—Protein intake was limited to 0.8–1.0 g/kg body weight/day. To ease
tracking, a protein point system was developed. Protein points were assigned to all proteinrich foods (meat, beans, dairy, protein-rich grains); one protein point was equal to
approximately seven grams of protein (i.e., one ounce of meat, one cup of milk, or ½ cup
dried beans). Participants were also taught how to convert food labels listing grams of
protein to protein points. Participants were encouraged to make the majority of reductions in
protein intake by eating less animal based protein sources.

Author Manuscript

2.7.3. Fruits and vegetables—The amount of fruits and vegetables prescribed was
calculated to reduce NEAP by 50% (minimum 40 mEq/day) after accounting for their
baseline fruit and vegetable intake. Because changes in NEAP are driven by changes in
PRAL in adults with stable body weight, increasing the intake of fruits and vegetables
decreases PRAL. Nutrient profiles from NDSR were used to calculate the PRAL per 100 g
of food according to Remer [23]. These values were converted into the amount of PRAL
reduction per serving of fruit or vegetable and given as a handout to the participants so they
could track their intake (i.e., adding 40 points of fruits and vegetables per day is equivalent
to reducing PRAL by 40 mEq). Participants were instructed on the number of points to eat
daily from fruits and vegetables.
2.7.4. Fluids—Since the goal was to reduce the urine osmolality to that of plasma or
below, we used baseline mean 24-h urine osmolality excretion to determine the total fluid
intake that would be needed to decrease the mean urine osmolality to ≤285 mosm/kg H2O/d;
an additional 20% was added to correct for insensible losses [25]. Assuming 1 kg fluid =
1000 ml of fluid, the daily fluid goal (mL/ d) = ((24-hr urine mosm/kg H2O/285 mosm/kg
H2O) × total urine volume (mL/d)) × 1.2.
For patients with baseline mean urine osmolality equal to plasma or less we prescribed
sufficient water to maintain urine osmolality at baseline levels.
2.8. Nutrition hassles questionnaire analysis
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This diet is formulated for lifetime use so understanding the participants’ views about the
extent of daily stress associated with nutritional issues is important. We adapted the
Nutrition Hassles Questionnaire (NHQ) to flesh out particular aspects of the diet, such as
concerns about the prescribed diet, planning menus, and eating the proper amounts, as well
as issues related to the manner in which the diet was tracked by participants, that might
impede wide acceptance [27]. The NHQ is a set of 33 items designed to assess the
perception of stress associated with the diet and is divided into three sections: hassles,
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uplifts, and self-efficacy. The hassles section includes 15 questions related to following the
diet, each rated on a 0–3 scale (0 = no hassle and 3 = severe hassle). It includes questions
aimed at uncovering issues associated with planning meals, preparing meals, and tracking
intake of dietary components. The uplifts section includes six questions about events that
made the participant feel good while following the diet and is rated on a 0–3 scale (0 = never
and 3 = very often). The self-efficacy section includes 12 questions about how confidently a
person identifies and selects appropriate foods for meals and snacks, prepares appropriate
foods, and their ability to follow the diet prescription. This section is rated on a 5 point scale
(1 = not confident at all and 5 = very confident).
2.9. Statistical analyses
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A paired samples t-test was used to compare two week and four week visit data to baseline
measurements. Mean results of the three day diet records, 24-h urine collections, and blood
pressures were analyzed with SPSS software [28]. Data were managed by REDCap (CTSA
Award # UL1TR000001). Differences were considered statistically significant at p ≤ 0.05.

3. Results
Baseline demographics data are listed in Table 2 of the 50 individuals approached about
participation in this diet intervention, twelve subjects signed consents and were enrolled. No
subjects withdrew from this study and no adverse events were reported. This cohort is a
cross-section of middle-aged, ADPKD patients with well-preserved eGFR.
3.1. Compliance
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Of the 12 subjects enrolled, one subject failed to record 3-day diet records and improperly
collected 24-h urine samples and was considered a failure, because data were unavailable or
unreliable. The remaining 11 subjects attended every study visit and brought completed diet
records and urine collections with them to each visit. Creatinine excretion at the two week
and four week visits was ~7% below baseline; however, this decrease is likely related to the
reduced intake of animal protein in the test diet and not incomplete collection of 24-h urine
samples [29].
3.2. Baseline

Author Manuscript

3.2.1. Dietary intake—Diet records revealed that the subjects at baseline were already
eating reasonably well-balanced amounts of protein, carbohydrates, and fat (Table 3);
however, energy intake was slightly more than recommended based on body size. Intake of
sodium and protein was somewhat higher than commonly recommended for ADPKD
subjects, but meat is a prominent component of most diets in the Midwest. The intake of
other mineral cations, including potential protons, was moderate except for potassium which
was relatively low. Due to the relatively high animal-sourced protein and low potassium
intake, baseline NEAP was acidic in all subjects (mean = 58 mEq/d). Baseline fluid intake
was variable averaging 3.2 L a day which is in the upper range of conventional intake but not
uncommon in ADPKD patients who are encouraged to drink extra water [30–33].
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3.2.2. Urine excretion—The extent to which the diet records reported what was actually
consumed was examined in the urine recovery of key solutes at baseline (Tables 3 and 4).
We did not expect perfect correspondence, because subjects were expected to make timed
collections and record diet consumption; however, the recoveries of sodium (95.9%), urea
(85.4%), and potassium (88.8%) were excellent. Urine volume was 558 ml less than the
intake reported in the diet record, likely due to insensible losses during the summer months.
The mean urine osmolality at baseline was skewed with 8 of 11 greater than plasma (285
mosm/kg H2O).
3.3. Treatment
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3.3.1. Intake—Subjects eating the test diet had an insignificant decrease in calorie intake, a
reduction in dietary fat and protein related to the lower animal protein intake, and an
increase in carbohydrates, related to the higher intake of fruits and starchy vegetables (Table
3). All macro nutrients remained within acceptable ranges.
Subjects also reached the goals for sodium (≤1.5 mmol/kg), protein (≤1 g/kg), and fluid
intake (urine osmolality ≤ 285 mosm/ kg) tailored for each patient; changes that were
sustained throughout the experimental period. Potassium intake increased 150% from
baseline; there was no change in calcium or magnesium. With the increase in potassium and
the reduction in protein, NEAP decreased from baseline by ~58 mEq/d at the two week and
four week visits.
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3.3.2. Urine excretion—Sodium excretion decreased (−20%) and potassium excretion
increased (+155%) reflecting the changes in the dietary prescription. Urea excretion and
urinary calcium decreased 28% and 29%, respectively, in response to the decrease in dietary
protein intake [34]. Urine magnesium excretion remained stable throughout the study. NAE
decreased 46% below baseline and was accompanied by a sustained rise in urine pH of
0.33/0.78 (mean/median) units (Table 4). Urine volume increased 35% above baseline
consistent with a 43% increase in fluid consumption and mean osmolality declined reaching
the 285 mosm/kg H2O target in 10/11 subjects (Tables 3 and 4).
3.4. Other findings
Body weight and BMI did not change whereas systolic blood pressure tended to decrease
during treatment possibly responding to the decrease in sodium intake and increases in
potassium intake (Table 5). BUN was significantly reduced reflecting the decreased animalsourced protein intake and serum potassium levels increased significantly secondary to the
increased intake of fruits and vegetables.
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3.5. Nutrition hassles questionnaire
3.5.1. Hassles—Overall, only one participant reported any of the hassles as “moderately
severe” and no hassles were reported as “extremely severe” (Table 6). “Somewhat severe”
hassles that are noteworthy include planning meals, tracking fruits and vegetables, tracking
protein points, tracking fluid intake, and cooking differently. Interestingly, 9 out of 11 (82%)
of participants reported that preparing meals was “not a hassle” while only 3 individuals
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(36%) felt that planning meals was “not a hassle” indicating that planning ahead was more
of a hassle than actually preparing the meals.
3.5.2. Uplifts—Of the 11 participants, five experienced uplifts such as cooking for
someone else, and meeting family and one’s own responsibilities whereas six did not (Table
6).
3.5.3. Self-efficacy—Ten out of 11 individuals felt “somewhat confident” or “very
confident” that they could manage the new diet (Table 6).

4. Discussion
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The relatively complex diet prescription used in this trial was designed to mitigate risk
factors that have recently been shown to associate with the development of large cystic
kidneys that progress at accelerated rates to renal failure. None of the individual components
in the diet is unique; however, the limitation of sodium and animal-sourced protein intake
together with the increased ingestion of fruits, vegetables and water has not been evaluated
previously in patients with ADPKD. Poor compliance with single component dietary
regimens, e.g. sodium, is relatively high in the population at large, so it would be reasonable
to suppose that adding more elements to the prescription would further undermine
meaningful acceptance. In this respect, ADPKD patients differ from the usual. Many
watched a parent or a sibling proceed along the path to kidney failure, dialysis and renal
transplantation and appear to be primed to follow medical regimens that may slow the
course of the disease. We were pleased to see, with the exception of one person, how well
the participants in this study mastered the complexities of diet preparation and record
keeping with only modest stress based on their responses to the hassles questionnaire.
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Dietary sodium intake has been extensively evaluated in hypertensive disorders and
limitations in the diet to a varying degree have been shown to have an important role in
bringing blood pressure into the normal range [35,36]. The hypertension commonly found in
ADPKD has an extracellular fluid volume-dependent component involving sodium retention
as well as increased renin release secondary to the effects of cysts on renal arterioles. In the
current study, the reduction in sodium intake was associated with a tendency for systolic
blood pressure to decrease, although remaining in the normal range. For reasons that are just
now being unraveled, high sodium intake is associated with larger kidneys and a faster
decline in renal function in ADPKD making sodium a lifestyle factor worthy of strict control
[6,37].
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The intake of animal-sourced protein has also been shown to affect cyst growth [38]. In the
Consortium for Radiologic Imaging of PKD (CRISP) study, ADPKD patients who excreted
the largest amounts of urea, a surrogate for protein intake, had larger kidneys that progressed
more rapidly to renal failure [6,38]. The mechanisms that render increased animal-sourced
protein intake harmful to polycystic kidneys are unknown. In the current study, animalsourced protein intake was reduced but not to extreme levels. To do otherwise would likely
defeat overall compliance and put patients at risk of protein-energy wasting.
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Normal kidneys buffer proton excretion with ammonium and phosphate, keeping the
concentration of hydrogen ions in plasma and urine relatively low and less likely to injure
nephrons. Increased acid excretion accelerated the progression of ADPKD in an animal
model of the disorder and the administration of alkali reversed the downward trend [5,8].
Recent studies of chronic progressive renal insufficiency in patients with hypertensive
nephropathy approaching the end-stage of the disease have exposed the harmful effects of
hydrogen ion excretion in patients eating regular diets containing abundant acid precursors
[9,39]. These findings were recently validated in a nationally representative cohort of
individuals with chronic kidney disease showing that individuals with higher dietary acid
intake progress to kidney failure more rapidly than their low dietary acid consuming peers
[14]. The mechanisms by which hydrogen ions stimulate renal cyst growth are unknown;
however, in light of these studies it seems rational to reduce the amount of dietary acids
precursors. In the current study, we show that patients with ADPKD will modify the intake
of fruits, vegetables, and animal-sourced protein sufficient to decrease the excretion of
protons in the urine for at least four weeks. NEAP was significantly reduced in the diet and
NAE was significantly reduced in the urine, corresponding metrics confirming that the diet
prescription met the goal of reducing the excretion of protons (Tables 3 and 4). In view of
the excellent recovery of other dietary components, we cannot account for finding the
change in NAE (−20.5 mEq) only 36% as great as NEAP (−57.5 mEq/d). Interestingly,
similar discrepancies between NEAP and NAE have previously been found in clinical trials
even when urine collections were performed in a clinical trials unit [9,15]. The discrepancy
between NEAP and NAE may reside in the estimate of endogenous organic acid (OA)
contributions to NEAP. As proposed by Remer et al., a greater percentage error may occur in
diets with a considerable intake of fruit since they contain certain acids that are incompletely
metabolized which are not taken into account in the estimation of OA [23].
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AVP is a major extrinsic factor that influences cyst growth in PKD [31,40]. An inhibitor
targeting the AVP-V2 receptor slowed disease progression in patients with ADPKD [41].
Studies in an animal model of PKD lead us to think that reducing plasma AVP levels by
increasing the intake of water might have a similar effect on cyst growth [16]. Urine
osmolality levels exceeding plasma values (~285 mosm/kg H2O) indicate that circulating
levels of AVP are high enough to increase water reabsorption in collecting ducts. In the
current study, baseline mean 24-h urine osmolality in ADPKD patients ranged from 170 to
480 mosm/kg H2O; values determined throughout the day or night could be higher or lower
than the 24-h mean value, but in general they run above plasma levels in the vast majority of
patients [6,42]. All of the subjects reduced urine osmolality below their individual baseline
values and in 91% osmolality was reduced below that of plasma, changes that would
certainly be associated with lowered levels of plasma AVP perfusing renal tubules and cysts.
Achieving an average 24-h osmolality goal of 285 mosm/kg H2O seems reasonable in the
short term until formal clinical trials produce results indicating that lower levels of urine
osmolality are more protective and can be achieved without harm.
The current study illustrates that in most patients with ADPKD good to excellent
compliance can be expected when modest limitations of salt and protein are combined with
an increased intake of fruits, vegetables, and fluids. Low sodium, low protein, and weight
loss diets are notoriously difficult to maintain over the long term and the increased water
Clin Nutr. Author manuscript; available in PMC 2018 April 01.
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drinking prescription to reduce urinary stone formation and shedding is commonly ignored
[43–46]. To counter these tendencies, in the current study we offered a palatable diet,
relatively simple to prepare, coupled with intense counseling at the outset. One of the 12
enrollees attended all of the sessions but was unable to record dietary information or collect
urine samples and we excluded the subject from the final analysis. In the remaining 11
subjects, >90% reported that none of the dietary hassles were worse than “somewhat
severe”, the lowest form of severity on the questionnaire, and the majority of patients felt at
least “somewhat confident” in their knowledge and abilities to follow the diet. We think a
treatment plan like this that frequently reinforces the importance of the diet as long-term
protection from kidney harm would likely gain acceptance by most patients with ADPKD
given the seriousness of the condition at the end stage.
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Limitations in this study include the small sample size and short duration dictated by
funding constraints, and a lack of kidney function markers that could monitor renal damage
and changes in function over such a short interval of time. Despite these concerns we
thought a pilot study of this relatively complex prescription was needed to determine if it
was reasonable to proceed to a more expansive and expensive clinical trial of sufficient
length to establish efficacy in respect to disease progression. We think the results support the
design and execution of a larger scale controlled clinical trial to determine if modifying
dietary components will slow the progression of ADPKD. Strengths in this study include
being the first to address the utility of attacking multiple dietary targets in ADPKD in
conjunction with multiple 24-h urine collections to verify diet records in an outpatient
setting.
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In conclusion, the experimental diet tested successfully in this study targets factors known to
accelerate the progression of ADPKD. Based on the urinary verification of dietary limits and
the good acceptance by the participants, we think this new PKD diet will help to justify a
controlled clinical trial to determine the extent to which dietary modifications may
ameliorate hypertension, renal pain, hematuria and the progression of biomarkers of renal
dysfunction in children and adults.
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AI

adequate intake

AMDR

acceptable macronutrient dietary range

AVP

arginine vasopressin

BMI

body mass index

BUN

blood urea nitrogen

CRISP

consortium for radiologic imaging of polycystic kidney disease

DRI

dietary recommended intake

eGFR

estimated glomerular filtration rate

GFR

glomerular filtration rate

NAE

net acid excretion

NE

Not established

NEAP

net endogenous acid production

NDSR

Nutrition Data for System Research

NHQ

Nutrition Hassles Questionnaire

OA

organic acids

PKD

polycystic kidney disease
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Fig. 1.

Diagram of the study protocol, study visit days, and data collected at visits. PKD, polycystic
kidney disease.

Author Manuscript
Author Manuscript
Clin Nutr. Author manuscript; available in PMC 2018 April 01.

Taylor et al.

Page 15

Table 1

Author Manuscript

Diet prescription.a

a

Diet component

Target level

Focus

Dietary Acids

Reduce NEAP by 50% (minimum 40
mEq/d)

Increased fruits and vegetables were prescribed using a new fruit and vegetable
point system.
1 point = 1 mEq reduction in NEAP.

Protein

0.8–1.0 g/kg body weight/d

A standard protein point system was prescribed to limit total protein intake,
primarily animal protein.

Sodium

1–1.5 mmol/kg body weight

Daily limits were apportioned to limits for each meal and snack based on the
individual’s usual dietary pattern. Sodium reduction guidelines from the American
Heart Association were also provided [26].

Fluid

Reduce urine osmolality to 285
mosm/kg H2O

Subjects were given exact volumes of fluid to drink throughout the day to reduce
urine osmolality to target level.

NEAP, net endogenous acid production.

Author Manuscript
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Table 2

Author Manuscript

Baseline descriptive features.a
Characteristic

Valueb

Number of participants, n (M/F)

11 (4/7)

Age (y)

47 ± 15

Caucasian, % (n)

91 (10)

African American, % (n)

9 (1)

Height (cm)

169.9 ± 9.5

Weight (kg)

71.3 ± 12.4

BMI

(kg/m2)

129 ± 11

Diastolic Blood pressure (mmHg)

77 ± 7

Author Manuscript

eGFR (ml/min/1.73

a

24.9 ± 5.1

Systolic Blood Pressure (mmHg)

m2)

84 ± 25

BMI, Body Mass Index; eGFR, estimated glomerular filtration rate.

b

All results either mean ± SD or % (n), unless otherwise indicated.
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Table 3

Author Manuscript

Dietary intake in 11 individuals with ADPKD by study visit.a
Recommendedb

Baseline

2 weeks

4 weeks

Energy Intakec (kcal)

1782–2138

2334 ± 416

2355 ± 425

2107 ± 399

Fat (% of energy)

20–35%

34.6 ± 5.4

26.8 ± 7.2**

25.2 ± 6.0***

NE

327 ± 138

185 ± 82**

192 ± 76*

45–65%

47.4 ± 7.9

59.1 ± 8.2***

61.6 ± 8.7***

21–38

20.4 ± 4.5

32.5 ± 7.4***

28.4 ± 6.8***

Protein (% of energy)

10–35%

17.0 ± 4.1

12.3 ± 2.7***

13.7 ± 4.3***

Protein (g/d)

Based on body weight

97.8 ± 25.9

70.9 ± 12.9**

69.9 ± 18.4**

Animal Protein (g/d)

NE

68.5 ± 24.7

37.5 ± 15.2***

40.9 ± 20.3**

Plant Protein (g/d)

NE

29.3 ± 7.2

33.3 ± 14.4

29.0 ± 6.8

Protein (g/kg)

0.8

1.39 ± 0.40

1.01 ± 0.19**

0.99 ± 0.25**

Fruits and vegetables (g/d)

NE

441 ± 258

1201 ± 355***

1214 ± 389***

2700–3700

3229 ± 573

4628 ± 855***

4575 ± 1076**

57–65

155.8 ± 45.7

102.8 ± 23.5**

99.0 ± 25.8**

2.26 ± 0.87

1.45 ± 0.29**

1.41 ± 0.37**

116 ± 21***

111 ± 24***

Nutrient intake

Cholesterol (mg/d)
Carbohydrates (% of energy)
Fiber (g/d)

Author Manuscript

Fluids
Fluids (mL/d)
Solute Intake
Sodium (mEq/d)
Sodium (mEq/kg)

–

Author Manuscript

Potassium (mEq/d)

120

74 ± 14

Calcium (mEq/d)

50–60

63 ± 26

68 ± 34

64 ± 32

Magnesium (mEq/d)

25.5–34.5

30 ± 7

39 ± 17

36 ± 17

Phosphorus (mEq/d)

45

94 ± 18

81 ± 13

75 ± 10**

Sulfur (mEq/d)

NE

9±3

OA (mEq/d)

NE

43.1 ± 3.8

PRAL (mEq/d)

NE

14.9 ± 20.0

−44.0 ± 24.0***

−41.7 ± 27.9***

NEAP (mEq/d)

NE

57.9 ± 21.4

−1.0 ± 23.6***

1.4 ± 28.0***

6 ± 1***
43.0 ± 3.7

6 ± 2***
43.1 ± 3.7

Dietary Acids

*

p 0.05 compared to baseline.

**

p 0.01 compared to baseline.

***

p 0.001 compared to baseline.

Author Manuscript

a

Values are means ± SDs. ADPKD, autosomal dominant polycystic kidney disease; AI, adequate intake; AMDR, acceptable macronutrient dietary
range; DRI, dietary recommended intake; NE, Not established; NEAP, net endogenous acid production; OA, organic acids; PRAL, potential renal
acid load.

b

Acceptable Macronutrient Dietary Range, Adequate Intake (ranges based on gender and age ranges), or Recommended Dietary Allowances
(ranges based on gender and age ranges) as appropriate.

c

Based on 25–30 kcal/kg actual body weight.
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Table 4

Author Manuscript

Urine constituents in 11 individuals with ADPKD by study visit.a
Baseline

2 weeks

4 weeks

Sodium (mEq/d)

149.4 ± 36.3

118.7 ± 42.9*

120.3 ± 35.5*

Potassium (mEq/d)

65.9 ± 12.7

101.9 ± 31.4***

102.5 ± 23.9***

Calcium (mEq/d)

8±3

6±3

6± 2**

Magnesium (mEq/d)

8±2

8±2

8± 3

Chloride (mEq/d)

147 ± 31

128 ± 42

130 ± 32

Phosphorus (mEq/d)

50 ± 13

43 ± 11*

47 ± 8

Sulfurb (mEq/d)

41 ± 8

31 ± 8***

32 ± 8***

Urea Nitrogen, (g/d)

11.17 ± 2.39

7.83 ± 2.47***

8.14 ± 2.30***

Uric Acid (mg/dL)

573 ± 99

527 ± 120

559 ± 87

Creatinine (mg/d)

1600 ± 294

1491 ± 254*

1495 ± 213*

Urine osmoles (mosm/d)

843 ± 121

718 ± 153**

726 ± 118*

Urine osmolality (mosm/kg)

335 ± 84

205 ± 55***

216 ± 70***

2671 ± 740

3642 ± 849***

3598 ± 1005*

Urine pHc (units)

5.90/6.06

6.26/6.90

6.21/6.78

Bicarbonate (mEq/d)

1.50 ± 1.20

3.45 ± 2.51**

3.91 ± 2.85**

Net Acid Excretion (mEq/d)

37.8 ± 14.3

18.1 ± 17.0***

16.6 ± 22.5***

Urinary Solute Excretion

Author Manuscript

Fluids
Urine volume (mL)
Urine acid-base excretion

Author Manuscript

*

p ≤ 0.05 compared to baseline.

**

p ≤ 0.01 compared to baseline.

***

p ≤ 0.001 compared to baseline.

a

Values are means ± SDs. ADPKD, autosomal dominant polycystic kidney disease.

b

Urinary sulfur was estimated based on an average content of methionine (2.4%) and cysteine (2.0%) from protein intake based on Remer’s
equation [23]. Protein intake was calculated from the urea excretion [47].

c
Mean/median.
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Table 5

Author Manuscript

Serum components, anthropometrics, and blood pressures in 11 individuals with ADPKD by study visit.a
Baseline

2 weeks

4 weeks

Sodium (mEq/L)

137 ± 2

138 ± 2

136 ± 1

Potassium (mEq/L)

3.8 ± 0.3

4.0 ± 0.3

4.1 ± 0.3**

Chloride (mEq/L)

104 ± 2

103 ± 2

103 ± 2

27 ± 2

27 ± 2

28 ± 2

7±2

7±3

6±2

Glucose (mg/dL)

83 ± 9

86 ± 10

87 ± 13

BUN (mg/dL)

20 ± 8

15 ± 8***

15 ± 9**

Serum

CO2 (mmol/L)
Anion Gap (mEq/L)

Creatinine (mg/dL)

Author Manuscript

0.97 ± 0.24

0.98 ± 0.32

0.98 ± 0.28

eGFR (ml/min/1.73 m2)

84 ± 25

85 ± 27

83 ± 26

Uric Acid (mg/dL)

4.8 ± 1.6

4.7 ± 1.5

4.8 ± 1.5

Calcium (mg/dL)

9.7 ± 0.3

9.7 ± 0.5

9.7 ± 0.3

Systolic (mmHg)

129 ± 11

120 ± 12*

123 ± 11

Diastolic (mmHg)

77 ± 7

77 ± 8

78 ± 8

Weight (kg)

71.3 ± 12.4

71.1 ± 12.1

71.3 ± 12.3

BMI (kg/m2)

24.9 ± 5.1

24.8 ± 5.0

24.9 ± 5.1

Blood Pressure

Anthropometrics

*

p ≤ 0.05 compared to baseline.

**

p ≤ 0.01 compared to baseline.

Author Manuscript

***

p 0.001 compared to baseline.

a
Values are means ± SDs. ADPKD, autosomal dominant polycystic kidney disease; BMI, body mass index; BUN, blood urea nitrogen; eGFR,
estimated glomerular filtration rate.
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Not at all confident
0
0
0

Identify appropriate food for meals and snacks

Choose appropriate foods to satisfy hunger

Prepare variety of fruits and vegetables

1 (9)

0

1 (9)

5 (45)

1 (9)

0

Self-efficacy

5 (45)

9 (82)

Using handouts that were given to follow diet

6 (55)

9 (82)

Grocery shopping

Helping to improve someone else’s health

10 (91)

Not fully understanding what to do

Being well-prepared

10 (91)

Concerns about other’s perceptions of your diet

5 (45)

8 (73)

Not enough time to prepare meals

4 (36)

9 (82)

Not enough time to plan meals

Cooking for someone else

7 (64)

Cooking differently

Eating out

8 (73)

Other individuals in your house won’t eat what is prepared

6 (55)

8 (73)

Limiting sodium in the diet

4 (36)

6 (55)

Tracking fluids for the day

Meeting your responsibilities

4 (36)

Tracking protein points

Meeting family responsibilities

6 (55)

Tracking fruits and vegetable points

Somewhat often

9 (82)

Preparing meals

No uplifts

10 (91)

Uplifts

4 (36)

Not enough money for food

Not a hassle

Number (%)

Planning meals

Hassles

0

0

0

0

2 (18)

4 (36)

5 (45)

1 (9)

4 (36)

4 (36)

2 (18)

1 (9)

0

1 (9)

3 (27)

0

Neutral

Extremely often

1 (9)

0

0

1 (9)

1 (9)

0

1 (9)

1 (9)

0

0

0

Moderately severe

Somewhat not confident

3 (28)

1 (9)

0

1 (9)

0

3 (27)

Moderately often

2 (18)

2 (18)

1 (9)

1 (9)

2 (18)

2 (18)

4 (36)

2 (18)

2 (18)

5 (45)

6 (55)

4 (36)

2 (18)

1 (9)

7 (64)

Somewhat severe

5 (45)

4 (36)

6 (55)

Somewhat confident

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Extremely severe

Author Manuscript

Hassles questionnaire responses in 11 individuals with ADPKD.a

3 (27)

3 (27)

5 (45)

Very confident

Author Manuscript
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0
0
0
0
0

Limit sodium in meals
Prepare high fruit/vegetable point meals
Prepare recipes that incorporated fruits/vegetables
Educate others about high fruit/vegetable point foods
Drink prescribed fluids

n (%) (all such values). ADPKD, autosomal dominant polycystic kidney disease.

a

0

Limit protein foods in the diet/follow restriction

0

1 (9)

Ask for help from family and friends when needed

Eat prescribed fruits/vegetables points

0

Author Manuscript
Not at all confident

1 (9)

1 (9)

2 (18)

0

1 (9)

1 (9)

0

1 (9)

1 (9)

Somewhat not confident

Author Manuscript

Provide meat as a side dish instead of an entree

2 (18)

2 (18)

1 (9)

0

1 (9)

1 (9)

1 (9)

1 (9)

4 (36)

Neutral

2 (18)

2 (18)

5 (45)

7 (64)

4 (36)

2 (18)

6 (55)

3 (27)

2 (18)

Somewhat confident

6 (55)

6 (55)

3 (27)

4 (36)

5 (45)

7 (64)

4 (36)

5 (45)

4 (36)

Very confident

Author Manuscript

Self-efficacy
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